Immune clues in rare lung disease explored
NCT ID NCT01208792
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better understand the role of autoimmunity in the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify immune markers that predict disease progression in pulmonary arterial hypertension.
- What could go wrong
- This is an observational study, not a treatment trial. Findings may not lead to direct therapies or apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Internal Medicine Department, Claude Huriez Hospital
Lille, 59000, France
-
Internal Medicine Department, Cochin Hospital
Paris, 75014, France
-
Pneumology Department, Antoine Béclère Hospital
Clamart, 92000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a new pill ease the strain of pulmonary arterial hypertension?
- A tiny sensor inside the lung could reveal hidden pressure problems after Life-Saving surgery
- Could a gut bacteria transplant ease a rare lung disease?
- Can a diabetes drug help the heart burn fuel better in pulmonary hypertension?